In the past two years, the cold chain turned into one of the most talked-about aspects of healthcare. Biotechnology company X-Therma in Richmond, CA, plans to improve the cold steps in the bioprocessing of cell and gene therapies with biomimetics.

Find the whole article here:  Genetic Engineering & Biotechnlogy News

This article is taken from Genetic Engineering & Biotechnlogy News | Mike May, PhD | April 27, 2022

Every day it seems you can find a headline somewhere describing the extraordinary progress scientists have made in developing cell and gene therapies for rare genetic diseases, a variety of cancers, and common ailments that affect most of the industrialized world. Genetic material is now common in vaccines, too, as scientists discovered that mRNA is an effective starting point for eliciting a strong immune response to SARS-COV-2. But besides their genetic components, all these medical products face a common challenge: they must be kept cold during storage and transport to remain viable until they can be used.

Unfortunately, current techniques for cryopreserving cells and tissues are not built to preserve medical products. But today, scientists and engineers are developing new tools such as protein-like “peptoids” that can make cold storage and transport easier, safer and more reliable.

Find the whole article here:  Technology Networks

This article is taken from Technology Networks | By Xiaoxi Wei and Mark Kline | Apr 11, 2022

Existing and emerging biotech advances are transforming the way we preserve and transport donated organs. While their methods may vary, all share a common end goal: saving more lives.

Find the whole article here:  Discover Magazine, by Allison Futterman | Apr 6

This article is taken from Discover Magazine By Allison Futterman | Apr 6, 2022 3:45 PM